Form 4 for TMO Thermo Fisher Scientific
Accepted 2024-02-08 00:00:00 ET · period of report 2024-02-07 · accession 0001127602-24-004033 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-02-08 | 2024-02-07 | TMO | Boxer Michael A | SVP, GC | M - OptEx | $192.98 | +14.6K | 27.5K | +113% | +$2.81M |
| D | 2024-02-08 | 2024-02-07 | TMO | Boxer Michael A | SVP, GC | S - Sale+OE | $562.00 | -14.6K | 12.9K | -53% | -$8.19M |
| D | 2024-02-08 | 2024-02-07 | TMO | Boxer Michael A | SVP, GC | M - OptEx | $0.00 | -14.6K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-07 | M | A | 14,566 | $192.98 | 27,467.06 | D | — | — | |
| 2 | Common | Common Stock | 2024-02-07 | S | D | 14,566 | $562.00 | 12,901.06 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2024-02-07 | M | D | 14,566 | $0.00 | 0 | D | $192.98 · 2021-03-07 to 2025-01-02 | 14,566 Common Stock |